Related Experiment Video
Updated: Sep 3, 2025
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
[Consideration on the Research and Development of New Drugs for Rare Tumors]
Ling Tang1, Yuanyuan Song1, Zhimin Yang1
1Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China.
Abstract:
In recent years, China's anti-tumor drugs has shown a continuous growth trend, and the activity of anti-tumor research and development in China accounts for a higher proportion in the world. However, further analysis of research and development hotspots show that the research and development of anti-tumor drugs is uneven among different tumor types. Due to the small number of the patients, it is difficult to conduct clinical trials, resulting in less drug development in the field of rare tumors. However, patients' treatment needs will also bring potential opportunities for pharmaceutical companies. The development of basic research and the discovery of new molecular tumor typing make "rare tumors" a dynamic concept. The scope of "rare tumors" may gradually expand with the precise development of treatment; or as the knowledge of tumors gradually develops from histocytology to the molecular level, It is possible that certain tumors with specific mutations can be combined into a group of non-rare "pan-tumors". Rare tumors are characterized by both rare diseases and tumors. Its drug research and development should not only meet the requirements of tumor drug research and development, but also adapt to the characteristics of rare diseases. Therefore, in the drug research and development, we can refer to the research and development principle of rare disease drugs, combine with the characteristics of tumor diseases, make full use of non-rare tumor clinical trials, make full use of scientific tools and exquisite trial design, and realize the promotion of the research and development of rare tumor drugs. This paper will summarize the thoughts in the review of new drugs in the field of rare tumors, in order to provide guidance for the industry. .
Insights
China
Area of Science:
- Oncology
- Pharmaceutical Research
- Drug Development
Background:
- China's anti-tumor drug research and development shows growth, but is uneven across tumor types.
- Rare tumor drug development faces challenges due to small patient populations and clinical trial difficulties.
- The concept of "rare tumors" is evolving with advances in molecular typing and precision medicine.
Purpose of the Study:
- To address the challenges in rare tumor drug development.
- To provide guidance for the pharmaceutical industry in developing drugs for rare tumors.
- To leverage existing knowledge and methodologies from rare disease and oncology drug development.
Main Methods:
- Reviewing current trends and challenges in rare tumor drug research.
- Analyzing the characteristics of rare tumors and rare disease drug development principles.
- Proposing strategies to adapt rare disease drug development principles for oncology.
Main Results:
- Drug development for rare tumors is hindered by patient numbers and trial design.
- Advances in molecular tumor classification may redefine "rare tumors" and create opportunities.
- Integrating rare disease drug development strategies with oncology principles is crucial.
Conclusions:
- Developing drugs for rare tumors requires a tailored approach, considering both rarity and tumor characteristics.
- Utilizing non-rare tumor clinical trials, scientific tools, and innovative trial designs can accelerate rare tumor drug development.
- This review offers insights to guide the industry in advancing rare tumor therapeutics.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
02:56Treatment Resistant Cancers
01:26Drug Discovery: Overview
01:11Clinical Trials: Overview
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:28Preclinical Development: Overview
01:02Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...